Clinical Cancer Drugs
Title:Preface:
Volume: 2
Author(s): Yuval Shaked
Affiliation:
Export Options
About this article
Cite this article as:
Shaked Yuval, Preface:, Clinical Cancer Drugs 2015; 2 (1) . https://dx.doi.org/10.2174/2212697X02999150204115845
DOI https://dx.doi.org/10.2174/2212697X02999150204115845 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radio-localization of Non-Palpable Breast Lesions Under Ultrasonographic Guidance: Current Status and Future Perspectives
Current Radiopharmaceuticals 2-Modified Oligonucleotides for Antisense Therapeutics
Current Topics in Medicinal Chemistry Drug Target Strategies in Breast Cancer Treatment: Recent Developments
Anti-Cancer Agents in Medicinal Chemistry Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism,Carbohydrate Metabolism, and Innate Immunity
Current Signal Transduction Therapy The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Ginsenosides as Potential Therapeutics Against Breast Cancer
Current Topics in Medicinal Chemistry Development and Validation of Predictive Molecular Signatures
Current Molecular Medicine Protein Secretome Analysis of Evolving and Responding Tumor Ecosystems
Current Proteomics Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Assays for Eukaryotic Cell Chemotaxis
Combinatorial Chemistry & High Throughput Screening Tissue Transglutaminase Expression During Neural Differentiation of Human Mesenchymal Stem Cells
CNS & Neurological Disorders - Drug Targets Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities
Current Drug Metabolism Age-Related Inflammation: the Contribution of Different Organs, Tissues and Systems. How to Face it for Therapeutic Approaches
Current Pharmaceutical Design Biofabrication of Reduced Graphene Oxide Nanosheets using Terminalia Bellirica Fruit Extract
Current Nanoscience A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
Anti-Cancer Agents in Medicinal Chemistry HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
Mini-Reviews in Medicinal Chemistry Diet After Cholecystectomy
Current Medicinal Chemistry Exploring PLAC1 Structure and Underlying Mechanisms to Design a Derivative Vaccine Against Breast Cancer Progression; <i>In-Silico</i> Study
Current Proteomics Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
Current Cancer Drug Targets Recent Advances in the Treatment of Multiple Myeloma
Current Pharmaceutical Biotechnology